Andrea E. Wahner Hendrickson

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial”.

Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30180-7

N/A

5.1DataRank · unranked

233 citations

Su-Chun Cheng, Andrea E. Wahner Hendrickson, Richard T. Penson, Susan Schumer, L. Austin Doyle +19 more

A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer

Cancer Chemotherapy and Pharmacology(2022)10.1007/s00280-022-04430-6

N/A

0.560DataRank · unranked

10 citations

Shannon Puhalla, Shalu Pahuja, Fei Ding, Yan Lin, Leonard J. Appleman +30 more

The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.03.018

N/A

0.415DataRank · unranked

10 citations

William P. Tew, Christopher Purdy, S. Dennis, Andrew Menzin, John L. Lovecchio +16 more

Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancer

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.102028

N/A

0.301DataRank · unranked

6 citations

Tara M. Davidson, Coriolan Lebreton, Leah A. Marsh, Deandra K. Chetram, Hunter J. Atkinson +14 more

Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.05.013

N/A

0.104DataRank · unranked

1 citations

Austin Miller, Judith A. Smith, Stuart M. Lichtman, Michael A. Bookman, Carol Aghajanian +17 more

Abrogation of group III phospholipase A2 inhibits tumor growth and metastasis in ovarian cancer and promotes chemo-sensitization

Research Square(2021)10.21203/rs.3.rs-147840/v1

N/A

0DataRank · unranked

0 citations

Debarshi Roy, Ling Jin, Prabhu Thirusangu, Julie K. Staub, Yinan Xiao +7 more

Symptom identification and management in epithelial ovarian cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5554

N/A

0DataRank · unranked

0 citations

Kathryn J. Ruddy, Deirdre R. Pachman, Kristin Fischer, Parvez Rahman, Krista M. Goergen +4 more

Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization

Journal of Experimental & Clinical Cancer Research(2021)10.1186/s13046-021-01985-9

N/A

0DataRank · unranked

27 citations

Debarshi Roy, Ling Jin, Prabhu Thirusangu, Julie K. Staub, Yinan Xiao +7 more

Characterization of a RAD51C -silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance

NAR Cancer(2021)10.1093/narcan/zcab028

N/A

0DataRank · unranked

37 citations

Cordelia D. McGehee, Ksenija Nesic, Cristina Correia, Taylor M. Weiskittel, Rebecca L. Kelly +28 more

A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer

Nature Communications(2021)10.1038/s41467-021-25904-w

N/A

0DataRank · unranked

69 citations

Alexandre André Balieiro Anastácio da Costa, D. Gulhan, Elizabeth K. Lee, Su-Chun Cheng, Andrea E. Wahner Hendrickson +14 more

Randomized phase 2 study of gemcitabine with or without ATR inhibitor berzosertib in platinum-resistant ovarian cancer: Final overall survival (OS) and biomarker analyses.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5512

N/A

0DataRank · unranked

6 citations

Elizabeth Katherine Lee, Su–Chun Cheng, Alexandre André Balieiro Anastácio da Costa, Andrea E. Wahner Hendrickson, D. Gulhan +14 more

Metformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.02.001

N/A

0DataRank · unranked

8 citations

Ernst Lengyel, Andrea E. Wahner Hendrickson, Gustavo C. Rodriguez, Charles A. Leath, Rodney P. Rocconi +6 more

Characterization of a RAD51C -Silenced High Grade Serous Ovarian Cancer Model During PARP Inhibitor Resistance Development

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.25.419978

N/A

0DataRank · unranked

2 citations

Cordelia D. McGehee, Ksenija Nesic, Cristina Correia, Taylor M. Weiskittel, Rebecca L. Kelly +25 more

Multi-center, international endometrial cancer consortium highlights

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.101805

N/A

0DataRank · unranked

3 citations

Anna Giudici, Vincenzo Tarantino, Stuart A. Ostby, Kelly H. Bruce, Daniel M. Breitkopf +28 more

Mitotic MTH1 inhibitor karonudib kills epithelial ovarian cancer independent of platinum sensitivity

Experimental Hematology and Oncology(2025)10.1186/s40164-025-00681-0

N/A

0DataRank · unranked

1 citations

Jill M. Wagner, Arun Kanakkanthara, Annapoorna Venkatachalam, Aaron M Deisinger, Cristina Correia +18 more

Codon specific readthrough as a mechanism of BRCA2 restoration in acquired PARP inhibitor and chemotherapy resistance

Nucleic Acids Research(2025)10.1093/nar/gkaf990

N/A

0DataRank · unranked

1 citations

X. Wei Meng, Xinyan Wu, Cristina Correia, Annapoorna Venkatachalam, Karen S. Flatten +15 more

CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trial

npj Breast Cancer(2025)10.1038/s41523-025-00830-y

N/A

0DataRank · unranked

1 citations

Karen S. Flatten, Taylor M. Weiskittel, Annapoorna Venkatachalam, Annabella R. Strathman, Olivia K. Rossman +17 more

Clinical effectiveness of best-evidence cancer distress management in a real-world practice setting

Translational Behavioral Medicine(2025)10.1093/tbm/ibaf030

N/A

0DataRank · unranked

0 citations

Janae L. Kirsch, Elizabeth L. Kacel, Lisa M. Gudenkauf, Sherrie Hanna, Eleshia J. P. Morrison +10 more